A catalyst for this unusual bearish activity remains unclear, but the company last week launched a membership plan that grants members access to doctors who can prescribe Novo Nordik’s (NVO) Ozempic and Wegovy for weight loss.

Source: https://www.forbes.com/sites/greatspeculations/2023/12/27/bears-target-heavily-shorted-ww-international-stock/

Novo Nordisk (NVO) shares are surging, up 51% in 2023.

Source: https://forextv.com/crypto-currency-news/novo-nordisk-relentless-inflows-send-shares-soaring/

The shape of the balance sheet is pleasing and the NVO governance is strong.

Source: https://seekingalpha.com/article/4654103-novo-nordisk-massive-reality-check-awaits-greedy-investors?source=feed_all_articles